Epigenetic activation of the foxa2 gene is required for maintaining the potential of neural precursor cells to differentiate into dopaminergic neurons after expansion

Stem Cells and Development

Volumn 24, Issue 4, 2015, Pages 520-533

  Bang, So Young ^a   Kwon, So Hee ^b   Yi, Sang Hoon ^c   Yi, Sang Ah ^a   Park, Eun Kyung ^a   Lee, Jae Cheol ^d   Jang, Choon Gon ^a   You, Jueng Soo ^e   Lee, Sang Hun ^c   Han, Jeung Whan ^a  

^a Sungkyunkwan University   (South Korea)

^b Yonsei University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APICIDIN; HISTONE DEACETYLASE 7; HISTONE H3; HISTONE H4; SHORT HAIRPIN RNA; FOXA2 PROTEIN, MOUSE; HDAC7 PROTEIN, MOUSE; HEPATOCYTE NUCLEAR FACTOR 3BETA; HISTONE; HISTONE DEACETYLASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EPIGENETICS; FOXA2 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HDAC7 GENE; HISTONE ACETYLATION; HISTONE MODIFICATION; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL EXPANSION; UPREGULATION; ANIMAL; CELL CULTURE; CYTOLOGY; EMBRYOLOGY; EMBRYONIC STEM CELL; GENETIC EPIGENESIS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; NERVOUS SYSTEM DEVELOPMENT;

ANIMALS; CELLS, CULTURED; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HISTONE DEACETYLASES; HISTONES; MESENCEPHALON; MICE; MICE, INBRED ICR; NEURAL STEM CELLS; NEUROGENESIS;

EID: 84923068636     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0218     Document Type: Article

References (41)

1. Meyer AK, A Jarosch, K Schurig, I Nuesslein, S Kienkötter and A Storch. (2012). Fetal mouse mesencephalic NPCs generate dopaminergic neurons from post-mitotic precursors and maintain long-term neural but not dopaminergic potential in vitro. Brain Res 1474:8-18.
2. Braak H and K Del Tredici. (2008). Assessing fetal nerve cell grafts in Parkinsons disease. Nat Med 14:483-485.
3. Delic J and H Zimmermann. (2010). Nucleotides affect neurogenesis and dopaminergic differentiation of mouse fetal midbrain-derived neural precursor cells. Purinergic Signal 6:417-428.
4. Ostenfeld T and CN Svendsen. (2004). Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells. Stem Cells 22:798-811.
5. Bouvier MM and C Mytilineou. (1995). Basic fibroblast growth factor increases division and delays differentiation of dopamine precursors in vitro. J Neurosci 15:7141-7149.
6. Studer L, M Csete, SH Lee, N Kabbani, J Walikonis, B Wold and R McKay. (2000). Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20:7377-7383.
7. Yan J, L Studer and RD McKay. (2001). Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J Neurochem 76:307-311.
8. Storch A, G Paul, M Csete, BO Boehm, PM Carvey, A Kupsch and J Schwarz. (2001). Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 170:317-325.
9. Bayly RD, CY Brown and S Agarwala. (2012). A novel role for FOXA2 and SHH in organizing midbrain signaling centers. Dev Biol 369:32-42.
10. Ferri AL, W Lin, YE Mavromatakis, JC Wang, H Sasaki, JA Whitsett and SL Ang. (2007). Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 134:2761-2769.
11. Norton WH, M Mangoli, Z Lele, HM Pogoda, B Diamond, S Mercurio, C Russell, H Teraoka, HL Stickney, et al. (2005). Monorail/Foxa2 regulates floorplate differentiation and specification of oligodendrocytes, serotonergic raphe neurones and cranial motoneurones. Development 132: 645-658.
12. Lee HS, EJ Bae, SH Yi, JW Shim, AY Jo, JS Kang, EH Yoon, YH Rhee, CH Park, et al. (2010). Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells 28:501-512.
13. Mikkelsen TS, M Ku, DB Jaffe, B Issac, E Lieberman, G Giannoukos, P Alvarez, W Brockman, TK Kim, et al. (2007). Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448:553-560.
14. Tanaka Y, I Naruse, T Hongo, M Xu, T Nakahata, T Maekawa and S Ishii. (2000). Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREBbinding protein. Mech Dev 95:133-145.
15. Yao TP, SP Oh, M Fuchs, ND Zhou, LE Chng, D Newsome, RT Bronson, E Li, DM Livingston and R Eckner. (1998). Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.
16. MacDonald JL and AJ Roskams. (2008). Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development. Dev Dyn 237:2256-2267.
17. Sun G, C Fu, C Shen and Y Shi. (2011). Histone deacetylases in neural stem cells and induced pluripotent stem cells. J Biomed Biotechnol 2011:835968.
18. Kwon SH, SH Ahn, YK Kim, GU Bae, JW Yoon, S Hong, HY Lee, YW Lee, HW Lee and JW Han. (2002). Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/ Fas ligand expression in human acute promyelocytic leukemia cells. J Biol Chem 277:2073-2080.
19. You JS, JK Kang, DW Seo, JH Park, JW Park, JC Lee, YJ Jeon, EJ Cho and JW Han. (2009). Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression. Cancer Res 69:5716-5725.
20. Deierborg T, D Soulet, L Roybon, V Hall and P Brundin. (2008). Emerging restorative treatments for Parkinsons disease. Prog Neurobiol 85:407-432.
21. Morizane A1, JY Li and P Brundin. (2008). From bench to bed: the potential of stem cells for the treatment of Parkinsons disease. Cell Tissue Res 331:323-336.
22. Vernon AC, EJ Smith, L Stevanato and M Modo. (2011). Selective activation of metabotropic glutamate receptor 7 induces inhibition of cellular proliferation and promotes astrocyte differentiation of ventral mesencephalon human neural stem/progenitor cells. Neurochem Int 59: 421-431.
23. Cowan CA, I Klimanskaya, J McMahon, J Atienza, J Witmyer, JP Zucker, S Wang, CC Morton, AP McMahon, D Powers and DA Melton. (2004). Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350:1353-1356.
24. Herszfeld D, E Wolvetang, E Langton-Bunker, TL Chung, AA Filipczyk, S Houssami, P Jamshidi, K Koh, AL Laslett, et al. (2006). CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol 24:351-357.
25. Maitra A, DE Arking, N Shivapurkar, M Ikeda, V Stastny, K Kassauei, G Sui, DJ Cutler, Y Liu, et al. (2005). Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099-1103.
26. Ostenfeld T, MA Caldwell, KR Prowse, MH Linskens, E Jauniaux and CN Svendsen. (2000). Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol 164:215-226.
27. Lin W, E Metzakopian, YE Mavromatakis, N Gao, N Balaskas, H Sasaki, J Briscoe, JA Whitsett, M Goulding, KH Kaestner and SL Ang. (2009). Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development. Dev Biol 333:386-396.
28. Kittappa R, WW Chang, RB Awatramani and RD McKay. (2007). The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol 5:e325.
29. Kim HJ. (2011). Stem cell potential in Parkinsons disease and molecular factors for the generation of dopamine neurons. Biochim Biophys Acta 1812:1-11.
30. Svendsen CN, MA Caldwell, J Shen, MG ter Borg, AE Rosser, P Tyers, S Karmiol and SB Dunnett. (1997). Longterm survival of human central nervous system progenitor cells transplanted into a rat model of Parkinsons disease. Exp Neurol 148:135-146.
31. Panowski SH, S Wolff, H Aguilaniu, J Durieux and A Dillin. (2007). PHA-4/Foxa mediates diet-restrictioninduced longevity of C. elegans. Nature 447:550-555.
32. Fischle W, F Dequiedt, MJ Hendzel, MG Guenther, MA Lazar, W Voelter and E Verdin. (2002). Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cells 9:45-57.
33. Bernstein BE, TS Mikkelsen, X Xie, M Kamal, DJ Huebert, J Cuff, B Fry, A Meissner, M Wernig, et al. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315-326.
34. Greenway DJ, M Street, A Jeffries and NJ Buckley. (2007). RE1 Silencing transcription factor maintains a repressive chromatin environment in embryonic hippocampal neural stem cells. Stem Cells 25:354-363.
35. Siebzehnrubl FA, R Buslei, IY Eyupoglu, S Seufert, E Hahnen and I Blumcke. (2007). Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Exp Brain Res 176:672-678.
36. Chen PS, GS Peng, G Li, S Yang, X Wu, CC Wang, B Wilson, RB Lu, PW Gean, DM Chuang and JS Hong. (2006). Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11:1116-1125.
37. Go HS, JE Seo, KC Kim, SM Han, P Kim, YS Kang, SH Han, CY Shin and KH Ko. (2011). Valproic acid inhibits neural progenitor cell death by activation of NF-kappaB signaling pathway and up-regulation of Bcl-XL. J Biomed Sci 18:48.
38. Pasini D, KH Hansen, J Christensen, K Agger, PA Cloos and K Helin. (2008). Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev 22:1345-1355.
39. Lee TI, RG Jenner, LA Boyer, MG Guenther, SS Levine, RM Kumar, B Chevalier, SE Johnstone, MF Cole, et al. (2006). Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125:301-313.
40. Sher F, R Rössler, N Brouwer, V Balasubramaniyan, E Boddeke and S Copray. (2008). Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells 26:2875-2883.
41. Donato R, EA Miljan, SJ Hines, S Aouabdi, K Pollock, S Patel, FA Edwards and JD Sinden. (2007). Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci 25:8-36.